BENLYSTA sol inj 200 mg/ml auto-injecteur 4 x 1 ml
7680665850023
CH-66585
L04AG04
07.15.0.
Reimbursement limitations:
BENLYSTA.Ein
Après la garantie de prise en charge des frais par l’assureur-maladie et consultation préalable du …
1 / 2
google
Details
- Product number
- 6658501
- CPT
- -
- Packaging group
- 4
- Unit
- Injektor(en), vorgefüllt/Pen
- Composition
- belimumabum 200 mg, natrii chloridum, arginini hydrochloridum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Benlysta, Lösung zur subkutanen Injektion (Autoinjektor)
Lösung
4
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1001.65
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2019
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 66585
- Drug name
- Benlysta, Lösung zur subkutanen Injektion (Autoinjektor)
- Galenic form
- LSPA
- ATC Code
- L04AG04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 29/06/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BENLYSTA sol inj 200 mg/ml auto-injecteur 4 x 1 ml
- Description (DE)
- BENLYSTA Inj Lös 200 mg/ml Autoinjektor 4 x 1 ml
- Market launch
- 29/06/2018
- Narcotic (BTM)
- No